Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.

We have measured plasma sterol composition in 14 subjects with sitosterolemia and xanthomatosis. In addition to elevated plasma phytosterol (campesterol 16 +/- 7 mg/dl and sitosterol 35 +/- 16 mg/dl) and normal to moderately high cholesterol levels (258 +/- 96 mg/dl), concentrations of 5 alpha-satur...

Full description

Bibliographic Details
Main Authors: G Salen, P O Kwiterovich, Jr, S Shefer, G S Tint, I Horak, V Shore, B Dayal, E Horak
Format: Article
Language:English
Published: Elsevier 1985-02-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S002222752034390X
_version_ 1819055485149511680
author G Salen
P O Kwiterovich, Jr
S Shefer
G S Tint
I Horak
V Shore
B Dayal
E Horak
author_facet G Salen
P O Kwiterovich, Jr
S Shefer
G S Tint
I Horak
V Shore
B Dayal
E Horak
author_sort G Salen
collection DOAJ
description We have measured plasma sterol composition in 14 subjects with sitosterolemia and xanthomatosis. In addition to elevated plasma phytosterol (campesterol 16 +/- 7 mg/dl and sitosterol 35 +/- 16 mg/dl) and normal to moderately high cholesterol levels (258 +/- 96 mg/dl), concentrations of 5 alpha-saturated stanols, cholestanol, 5 alpha-campestanol, and 5 alpha-sitostanol were at least 10 times greater than controls. Diets contained plentiful quantities of cholesterol and plant sterols, but only trace amounts of cholestanol (less than 2 mg/day) and no detectable 5 alpha-campestanol and 5 alpha-sitostanol, which indicated that the 5 alpha-saturated stanols were formed endogenously. Treatment with cholestyramine reduced plasma cholesterol and phytosterol levels by 45% and 5 alpha-saturated stanols by 55%. These results indicate that abnormally high plasma concentrations of cholestanol, 5 alpha-campestanol, and 5 alpha-sitostanol are found in subjects with sitosterolemia and xanthomatosis, and that treatment with cholestyramine effectively reduced elevated plasma sterol levels.
first_indexed 2024-12-21T13:08:16Z
format Article
id doaj.art-d72646ae98034347a6d37e99c82226e5
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-21T13:08:16Z
publishDate 1985-02-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-d72646ae98034347a6d37e99c82226e52022-12-21T19:02:58ZengElsevierJournal of Lipid Research0022-22751985-02-01262203209Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.G SalenP O Kwiterovich, JrS SheferG S TintI HorakV ShoreB DayalE HorakWe have measured plasma sterol composition in 14 subjects with sitosterolemia and xanthomatosis. In addition to elevated plasma phytosterol (campesterol 16 +/- 7 mg/dl and sitosterol 35 +/- 16 mg/dl) and normal to moderately high cholesterol levels (258 +/- 96 mg/dl), concentrations of 5 alpha-saturated stanols, cholestanol, 5 alpha-campestanol, and 5 alpha-sitostanol were at least 10 times greater than controls. Diets contained plentiful quantities of cholesterol and plant sterols, but only trace amounts of cholestanol (less than 2 mg/day) and no detectable 5 alpha-campestanol and 5 alpha-sitostanol, which indicated that the 5 alpha-saturated stanols were formed endogenously. Treatment with cholestyramine reduced plasma cholesterol and phytosterol levels by 45% and 5 alpha-saturated stanols by 55%. These results indicate that abnormally high plasma concentrations of cholestanol, 5 alpha-campestanol, and 5 alpha-sitostanol are found in subjects with sitosterolemia and xanthomatosis, and that treatment with cholestyramine effectively reduced elevated plasma sterol levels.http://www.sciencedirect.com/science/article/pii/S002222752034390X
spellingShingle G Salen
P O Kwiterovich, Jr
S Shefer
G S Tint
I Horak
V Shore
B Dayal
E Horak
Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
Journal of Lipid Research
title Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
title_full Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
title_fullStr Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
title_full_unstemmed Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
title_short Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
title_sort increased plasma cholestanol and 5 alpha saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis
url http://www.sciencedirect.com/science/article/pii/S002222752034390X
work_keys_str_mv AT gsalen increasedplasmacholestanoland5alphasaturatedplantsterolderivativesinsubjectswithsitosterolemiaandxanthomatosis
AT pokwiterovichjr increasedplasmacholestanoland5alphasaturatedplantsterolderivativesinsubjectswithsitosterolemiaandxanthomatosis
AT sshefer increasedplasmacholestanoland5alphasaturatedplantsterolderivativesinsubjectswithsitosterolemiaandxanthomatosis
AT gstint increasedplasmacholestanoland5alphasaturatedplantsterolderivativesinsubjectswithsitosterolemiaandxanthomatosis
AT ihorak increasedplasmacholestanoland5alphasaturatedplantsterolderivativesinsubjectswithsitosterolemiaandxanthomatosis
AT vshore increasedplasmacholestanoland5alphasaturatedplantsterolderivativesinsubjectswithsitosterolemiaandxanthomatosis
AT bdayal increasedplasmacholestanoland5alphasaturatedplantsterolderivativesinsubjectswithsitosterolemiaandxanthomatosis
AT ehorak increasedplasmacholestanoland5alphasaturatedplantsterolderivativesinsubjectswithsitosterolemiaandxanthomatosis